These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 22454071)
21. U7 snRNA, a Small RNA with a Big Impact in Gene Therapy. Lesman D; Rodriguez Y; Rajakumar D; Wein N Hum Gene Ther; 2021 Nov; 32(21-22):1317-1329. PubMed ID: 34139889 [TBL] [Abstract][Full Text] [Related]
22. The special Sm core structure of the U7 snRNP: far-reaching significance of a small nuclear ribonucleoprotein. Schümperli D; Pillai RS Cell Mol Life Sci; 2004 Oct; 61(19-20):2560-70. PubMed ID: 15526162 [TBL] [Abstract][Full Text] [Related]
23. Therapeutics that directly increase SMN expression to treat spinal muscular atrophy. Shababi M; Mattis VB; Lorson CL Drug News Perspect; 2010 Oct; 23(8):475-82. PubMed ID: 21031163 [TBL] [Abstract][Full Text] [Related]
24. An intronic element contributes to splicing repression in spinal muscular atrophy. Kashima T; Rao N; Manley JL Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3426-31. PubMed ID: 17307868 [TBL] [Abstract][Full Text] [Related]
25. U7 snRNA-mediated correction of aberrant splicing caused by activation of cryptic splice sites. Uchikawa H; Fujii K; Kohno Y; Katsumata N; Nagao K; Yamada M; Miyashita T J Hum Genet; 2007; 52(11):891-897. PubMed ID: 17851636 [TBL] [Abstract][Full Text] [Related]
28. Sequence and expression of a mouse U7 snRNA type II pseudogene. Phillips SC; Turner PC DNA Seq; 1991; 1(6):401-4. PubMed ID: 1768864 [TBL] [Abstract][Full Text] [Related]
29. Engineered U7 Small Nuclear RNA Restores Correct β-Globin Pre-mRNA Splicing in Mouse β d'Arqom A; Nualkaew T; Jearawiriyapaisarn N; Kole R; Svasti S Hum Gene Ther; 2021 May; 32(9-10):473-480. PubMed ID: 32977730 [TBL] [Abstract][Full Text] [Related]
30. The Cellular Processing Capacity Limits the Amounts of Chimeric U7 snRNA Available for Antisense Delivery. Eckenfelder A; Tordo J; Babbs A; Davies KE; Goyenvalle A; Danos O Mol Ther Nucleic Acids; 2012 Jun; 1(6):e31. PubMed ID: 23344083 [TBL] [Abstract][Full Text] [Related]
35. Usage of U7 snRNA in gene therapy of hemoglobin S disorder - is it feasible? Wiwanitkit V Turk J Haematol; 2009 Sep; 26(3):159-60. PubMed ID: 27265503 [TBL] [Abstract][Full Text] [Related]
36. Targeting Splicing in the Treatment of Human Disease. Suñé-Pou M; Prieto-Sánchez S; Boyero-Corral S; Moreno-Castro C; El Yousfi Y; Suñé-Negre JM; Hernández-Munain C; Suñé C Genes (Basel); 2017 Feb; 8(3):. PubMed ID: 28245575 [TBL] [Abstract][Full Text] [Related]
37. Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice. Barman-Aksözen J; C Wiek P; Bansode VB; Koentgen F; Trüb J; Pelczar P; Cinelli P; Schneider-Yin X; Schümperli D; Minder EI Dis Model Mech; 2017 Mar; 10(3):225-233. PubMed ID: 28093505 [TBL] [Abstract][Full Text] [Related]
38. Double-target Antisense U1snRNAs Correct Mis-splicing Due to c.639+861C>T and c.639+919G>A GLA Deep Intronic Mutations. Ferri L; Covello G; Caciotti A; Guerrini R; Denti MA; Morrone A Mol Ther Nucleic Acids; 2016 Oct; 5(10):e380. PubMed ID: 27779620 [TBL] [Abstract][Full Text] [Related]